To quantify the expression of GPR182 on lymphatics we measured mean fluorescent intensity (MFI) of GPR182 on PDPN+ lymphatic vessels; we observed a marked increase in GPR182 expression in melanoma-associated lymphatic vessels compared to lymphatics in adjacent normal skin (Fig. 1f). The gene discussed is ACKR5; the disease is melanoma.